Aegerion Pharmaceuticals


About Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is an indirect subsidiary of Novelion Therapeutics, a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. For information about lipodystrophy, go to